Optimer | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,520 results for “Optimer”

Trials

View all 1430 →

Optimized Referral of Knee Patients to the Orthopedic Outpatient Clinic

226 participants · First posted Feb 4, 2016

Optimized Referral of Knee Patients at the Clinic of Sports Injuries

182 participants · First posted Feb 3, 2016

OPTImal Management of Antithrombotic Agents: OPTIMA-5

80 participants · First posted Oct 7, 2019

Drugs

View all 28 →

macrolide anti-inflammatories (Melinta therapeutics)

DIME (Octamer)

ApIS(Aptamer)

Organizations

View all 12 →

Optimed Medizinische Instrumente GmbH

Germany

OPTMED INC

United States

PGIMER-CHANDIGARH

India

News

View all 50 →

Aptamer and Invizius Partner to Develop Next-Generation Complement System Therapies Using Synthetic Binders

Aptamer Group Secures New Development Contracts and Licensing Deal for Synthetic Antibody Alternatives

Aptamer Group Launches Radiopharmaceutical Program with Enhanced Stability Profile

Page 1 of 152